← Back to Search

tFUS Brain Imaging for Brain Cancer

N/A
Recruiting
Led By David Darrow, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new non-invasive imaging and treatment of the brain, allowing high resolution imaging while offering reduced cost and improved treatment options.

Who is the study for?
This trial is for adults who are scheduled for brain surgery, can give informed consent, and will be under general anesthesia. They must have detailed contrast imaging of the brain available and use neuronavigation during surgery. It's not for those with scalp wounds/infections, significant health risks as judged by the lead researcher, or pregnant individuals.
What is being tested?
The study tests if transcranial focused ultrasound (tFUS) can effectively target and image brain tumors compared to MRI. tFUS may offer a cheaper alternative with better time resolution without invasive procedures like neuromodulation or thermal ablation that MRI-guided treatments require.
What are the potential side effects?
Since this trial focuses on imaging rather than treatment, side effects are minimal but could include discomfort from wearing the ultrasound device or rare allergic reactions to any contrast agent used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Test feasibility
Secondary study objectives
Morphology assessment
Volume assessment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental groupExperimental Treatment1 Intervention
Participants scheduled for brain surgery

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,434 Previous Clinical Trials
1,621,687 Total Patients Enrolled
David Darrow, MDPrincipal InvestigatorUniversity of Minnesota
5 Previous Clinical Trials
210 Total Patients Enrolled

Media Library

Experimental group Clinical Trial Eligibility Overview. Trial Name: NCT05755399 — N/A
Cranial Neurosurgery Research Study Groups: Experimental group
Cranial Neurosurgery Clinical Trial 2023: Experimental group Highlights & Side Effects. Trial Name: NCT05755399 — N/A
Experimental group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755399 — N/A
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top